AR021427A1 - Compuestos de benzimidazol que son antagonistas de receptor de vitronectina - Google Patents

Compuestos de benzimidazol que son antagonistas de receptor de vitronectina

Info

Publication number
AR021427A1
AR021427A1 ARP990106061A ARP990106061A AR021427A1 AR 021427 A1 AR021427 A1 AR 021427A1 AR P990106061 A ARP990106061 A AR P990106061A AR P990106061 A ARP990106061 A AR P990106061A AR 021427 A1 AR021427 A1 AR 021427A1
Authority
AR
Argentina
Prior art keywords
alkyl
arylcycloalkyl
heterocycloalkylalkyl
heteroaralkyl
cycloalkylalkyl
Prior art date
Application number
ARP990106061A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR021427A1 publication Critical patent/AR021427A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990106061A 1998-11-30 1999-11-29 Compuestos de benzimidazol que son antagonistas de receptor de vitronectina AR021427A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20161198A 1998-11-30 1998-11-30

Publications (1)

Publication Number Publication Date
AR021427A1 true AR021427A1 (es) 2002-07-17

Family

ID=22746536

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106061A AR021427A1 (es) 1998-11-30 1999-11-29 Compuestos de benzimidazol que son antagonistas de receptor de vitronectina

Country Status (12)

Country Link
EP (1) EP1135374B9 (https=)
JP (1) JP4480117B2 (https=)
CN (1) CN1161340C (https=)
AR (1) AR021427A1 (https=)
AT (1) ATE338751T1 (https=)
AU (1) AU1908400A (https=)
CA (1) CA2353063C (https=)
CO (1) CO5140112A1 (https=)
DE (1) DE69933135T2 (https=)
ES (1) ES2273517T3 (https=)
PE (1) PE20001427A1 (https=)
WO (1) WO2000032578A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148349C (zh) * 1999-04-07 2004-05-05 参天制药株式会社 N-取代-N′-取代脲衍生物及其用作TNF-α生成抑制剂的用途
DE60023492T2 (de) * 1999-05-17 2006-07-20 Novo Nordisk A/S Glucagon antagonisten/inverse agonisten
FR2809396B1 (fr) * 2000-05-24 2005-10-14 Centre Nat Rech Scient Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
US6562807B2 (en) 2000-06-23 2003-05-13 Novo Nordisk A/S Glucagon antagonists/inverse agonists
WO2008148845A2 (en) 2007-06-07 2008-12-11 Novozymes A/S Method of preparing a dough-based product
EP2595488B1 (en) 2010-07-21 2019-12-04 Novozymes A/S Process for preparing a baked product with anti-staling amylase and peptidase
EA031655B1 (ru) 2014-02-11 2019-02-28 Байер Фарма Акциенгезельшафт Бензимидазол-2-амины в качестве ингибиторов midhi
US9951027B2 (en) 2014-02-11 2018-04-24 Bayer Pharma Aktiengesellschaft Benzimidazol-2-amines as MIDH1 inhibitors
CN104694290A (zh) * 2014-05-07 2015-06-10 宁波职业技术学院 一种洗脚皂
WO2016062677A1 (en) 2014-10-23 2016-04-28 Bayer Pharma Aktiengesellschaft Benzimidazol-2-amines as midh1 inhibitors
JP6672288B2 (ja) 2014-10-23 2020-03-25 バイエル・ファルマ・アクティエンゲゼルシャフト 腫瘍の治療のためのmidh1阻害剤としての1−シクロヘキシル−2−フェニルアミノベンゾイミダゾール
EP3303302B1 (en) 2015-06-08 2019-03-20 Bayer Pharma Aktiengesellschaft N-menthylbenzimidazoles as midh1 inhibitors
JP6824954B2 (ja) 2015-07-16 2021-02-03 ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ mIDH1阻害剤としての5−ヒドロキシアルキルベンズイミダゾール
TW202146416A (zh) 2019-12-11 2021-12-16 德商拜耳廠股份有限公司 吡唑并三𠯤
WO2021176045A1 (en) 2020-03-06 2021-09-10 Bayer Aktiengesellschaft Imidazotriazines acting on cancer via inhibition of cdk12

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10501222A (ja) * 1994-05-27 1998-02-03 メルク エンド カンパニー インコーポレーテッド 破骨細胞仲介骨吸収を抑制するための化合物
NZ290008A (en) * 1994-06-29 1998-08-26 Smithkline Beecham Corp Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle

Also Published As

Publication number Publication date
WO2000032578A1 (en) 2000-06-08
WO2000032578A8 (en) 2002-02-07
CA2353063C (en) 2009-06-16
ATE338751T1 (de) 2006-09-15
CA2353063A1 (en) 2000-06-08
EP1135374A1 (en) 2001-09-26
EP1135374B1 (en) 2006-09-06
AU1908400A (en) 2000-06-19
DE69933135T2 (de) 2007-08-09
CN1161340C (zh) 2004-08-11
DE69933135D1 (de) 2006-10-19
JP4480117B2 (ja) 2010-06-16
PE20001427A1 (es) 2000-12-18
JP2002531441A (ja) 2002-09-24
ES2273517T3 (es) 2007-05-01
CN1333755A (zh) 2002-01-30
EP1135374B9 (en) 2007-02-21
CO5140112A1 (es) 2002-03-22

Similar Documents

Publication Publication Date Title
AR021427A1 (es) Compuestos de benzimidazol que son antagonistas de receptor de vitronectina
PL367105A1 (en) Quinoline derivative having azolyl group and quinazoline derivative
ATE137739T1 (de) N-acetonylbenzamide und ihre verwendung des fungizide
ATE447971T1 (de) Antipruriginosa
DE69308229D1 (de) N-isoxazol-phenylsulfonamid Derivate und ihre Anwendung als Endothelin-Antagonisten
DK1414302T3 (da) 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe
BR9706792A (pt) Derivado de tiazol
BR9909369A (pt) Compostos de ftalazina e agentes terapêuticos para disfunção eréctil
BG99863A (bg) Антагонисти на фибриногеновия рецептор
DE60206505D1 (de) Substituierte benzopyran derivate gegen arrhythmie
WO2003018549A3 (en) Bicyclic compounds as inhibitors of chemokine binding to us28
ATE277017T1 (de) 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
NO951811L (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
ES8304073A1 (es) Un procedimiento para la preparacion de n-fenilcarbamatos.
ES2078876A1 (es) Una composicion herbicida a base de fenilpirazol 3-sustituidos.
ITTO910235A1 (it) Scudo parasismico per la protezione di costruzioni civili dagli effetti di movimenti tellurici
KR910004562A (ko) 신규 아릴피롤 화합물 및 이들의 제조방법
GB2000508A (en) Thiazolidine compounds
EA200001034A1 (ru) Способ ингибирования mrp1
CO4810290A1 (es) Composiciones pesticidas
ES2186160T3 (es) Procedimiento de preparacion de ceto-enaminas sustituidas.
ECSP993245A (es) Compuestos de benzimidazol que son antagonistas de receptor de vitronectina
NO801615L (no) Stabiliserte halogenhydrocarboner.
BR9914504A (pt) Agente de estabilização
WO2000020399A3 (de) Verwendung von substituierten 5-hydroxypyrazolen, neue 5-hydroxypyrazole, verfahren zu deren herstellung, sowie sie enthaltende mittel

Legal Events

Date Code Title Description
FB Suspension of granting procedure